1 |
Kapranos N, Stathopoulos G. P, Manolopoulos L, Kokka E, Con. Papadimitriou, Bibas A, Yiotakis J, Adamopoulos G. p53, p21 and p27 Protein Expression in Head and Neck Cancer and their Prognostic Value. Anticancer Research 21:521-528, 2001.
|
2 |
Annette Schmider, Conway Gee, Wolfgang Friedmann, Jason J. Lukas, Michael F. Press, Werner Lichtenegger, Angela Reles. p21(WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Gynecologic Oncology 77:237-242, 2000.
|
3 |
Ng I. O. L, Lam K. Y, Ng M, Regezi J. A. Expression of p21/waf1 in oral squamous cell carcinomas - correlation with p53 and mdm2 and cellular proliferation index. Oral Oncology 35:63-69, 1999.
|
4 |
Agarwal S, Mathur M, Shukla N. K, Ralhan R. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. Oral Oncology 34:353-360, 1998.
DOI
ScienceOn
|
5 |
Shin D. M, Lee J. S, Lippman S. M. p53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 88:519-529, 1996.
|
6 |
Kumamoto Hiroyuki, Kimi Kenji, Ooya Kiyoshi. Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 30(5):309-315, 2001.
DOI
ScienceOn
|
7 |
Kumamoto Hiroyuki. Detection of apoptosisrelated factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 26:419-442, 1997.
DOI
ScienceOn
|
8 |
Lu S, Tiekso J, Hietanen S, Syrja¨nen K, HavuV. K, Syrj nen S. Expression of Cell-cycle Proteins p53, p21 (WAF-1), PCNA and Ki-67 in Benign, Premalignant and Malignant Skin Lesions with Implicated HPV Involvement. Acta Derm Venereol 79:268-273, 1999.
DOI
ScienceOn
|
9 |
Xin Li, Ai-Min Hui, Tadatoshi Takayama, Xing Cui, Yazhou Shi, Masatoshi Makuuchi. Altered p21waf1/cip1 expression is associated with poor prognosis in extrahepatic bile duct carcinoma. Cancer Letters 154:85-91, 2000.
DOI
ScienceOn
|
10 |
Costa M. J, Hansen C. L, Walls J. E, Scudder S. A. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasm: p21WAF/CIP1 predicts survival and good response to platinin-based chemotherapy. Hum Pathol 30:640-647, 1999.
|
11 |
Steven A. Ahrendt, Heather M. Brown, Richard A. Komorowski, Yong-ran Zhu, Stuart D. Wilson, Beth A. Erickson, Paul S. Ritch, Henry A. Pitt, Michael J. Demeure. p21waf1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Surgery 128:520-528, 2000.
|
12 |
Michieli P, Chedid M, Lin D, Pierce J. H, Mercer W. E, Givol D. Induction of WAF/cip1 by a p53-independent pathway. Cancer 54:3391-3395, 1995.
|
13 |
Tahara E. Molecular biology of gastric cancer. World J Surg 19:484-490, 1995.
DOI
PUBMED
ScienceOn
|
14 |
Staffan Jahnson, Mats G. Karisson. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma. Cancer 89:619-629, 2000.
DOI
ScienceOn
|
15 |
Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncology 37:193-198, 2001.
DOI
ScienceOn
|
16 |
Yook J. I, Kim J. Expression of p21(WAF1/CIP1) is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncology 34:198-203, 1998.
DOI
ScienceOn
|
17 |
Ozcelik H, Mousses, Andrulis I. L. Low levels of expression of an inhibition of cyclindependent kinases(CIP1/WAF1) in primary breast carcinomas with p53 mutations. Clin Cancer Res 1:907-912, 1995.
PUBMED
|
18 |
Chang Kuo-Wei, Lin Shu-Chun, Kwan Po-Cheung, Wong Yong-Kie. Association of aberrant p53 and p21waf1 immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 29, 56-62, 2000.
|
19 |
Ceccarelli C, Santini D, Chielco P, Lanciotti C, Taffurelli M, Paladini G, Marrano D. Quantitive p21waf1/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators. Int J Cancer 95:128-34, 2001.
DOI
ScienceOn
|
20 |
van Oijen M. G. C. T, Tilanus M. G. J, Medema R. H, Slootweg, P. J. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 27:367-37, 1998.
|
21 |
Tatemoto Y, Osaki T, Yoneda K, Yamamoto T, Veta E, Kimura T. Expression of p53 and p21 proteins in oral and squamous cell carcinoma: Correlation with lymph node metastasis and response to chemotherapy. Pathol Res Pract 194:821-830, 1998.
DOI
PUBMED
ScienceOn
|
22 |
Datto M. B, Li Y. Panus J. F, Howe D. J, Xiong Y, Wang X. F. Transforming growth factor induces the cyclin-dependent kinase inhibitor p21 through p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549, 1995.
|